Alnylam Pharmaceuticals, Inc. vs United Parcel Service Inc — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $221.5 (market cap $29.60B), while United Parcel Service Inc trades at $104.62 (market cap $88.85B). The key difference: United Parcel Service Inc is far larger — about 3× Alnylam Pharmaceuticals, Inc.'s market cap, and United Parcel Service Inc pays a 6.28% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.
| ALNY | UPS | |
|---|---|---|
Market Cap | $29.60B | $88.85B |
Sector | Health | Industrials |
52-Week High | $491.22 | $120.00 |
52-Week Low | $205.48 | $82.58 |
Enterprise Value | $27.56B | $112.87B |
Volume | — | 2,288,643 |
Dividend Yield | — | 6.28% |
Trailing returns across standard periods
Latest headlines on both assets
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →